Effects of Qing Chang Suppository Powder and its Ingredients on IL-17 Signal Pathway in HT-29 Cells and DSS-induced Mice

Gui Zhou,Wei-Song Kong,Zhi-Cheng Li,Rui-Fang Xie,Tian-Yuan Yu,Xin Zhou

DOI: https://doi.org/10.1016/j.phymed.2021.153573

IF: 6.656

2021-07-01

Phytomedicine

Abstract:Background: Qingchang Suppository, a formula used for more than 30 years in Longhua Hospital, has shown satisfactory clinical effects on Ulcerative Colitis (UC). However, its therapeutic mechanism has not been fully elucidated.Purpose: The study aims to investigate the effects of Qingchang Suppository powder (QCSP) and its ingredients by regulating the IL-17A signaling pathway which plays an important role in the development of UC.Methods: HPLC was used to analyze the main ingredients (Gallic acid, Indigo, Indirubin) in QCSP. HT-29 cells were induced by rhIL-17A and TNF-α, and IL-17A related protein expressions were determined by western blot. BALB/C mice were induced by 4% Dextran Sodium sulfate (DSS). The effects of QCS and its ingredients were evaluated by measuring weight loss, disease activity index (DAI), colon length, histological analysis. Western blot was used for analysis of IL-17A and MAPK related proteins p-ERK, p-JNK, p-P38. Quantitative reverse transcription polymerase chain reaction (q-PCR) was used to detect the expression of IL-17A, HSP90 and ACT1 in colon tissue. Cytokines such as IL-17A, IL-1β, IFN-γ and TNF-α were determinated by enzyme-linked immunosorbent assay (ELISA).Results: QCS had good therapeutic effect on DSS-induced colitis in mice. QCSP significantly relieved weight loss, restored colon length, repaired colon lesions, reduced histological scores and DAI, decreased TNF-α, IL-1β, IL-17 and IFN-γ contents, significantly suppressed the gene expressions of IL-17A, ACT1 and HSP90, and up-regulated the expressions of tight junction proteins like ZO-1 and Occludin. IL-17A pathway related proteins such as IL-17A, IL-17RA, HSP90, MAPKs, P-iκbα and iNOS were significantly increased in vitro and in vivo.Conclusions: This paper reveals that QCSP inhibited the IL-17A signaling pathway in HT-29 cells and DSS induced mice, presenting a new mechanism of QCS on treating UC..

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism of action of Qing Chang Suppository (QCS) and its components in the treatment of ulcerative colitis (UC) by regulating the IL - 17A signaling pathway. Specifically, the study aims to evaluate the effects of QCS and its main components (such as gallic acid, flavonoids, etc.) on the IL - 17A signaling pathway through in vitro (HT - 29 cells) and in vivo (DSS - induced BALB/C mice) experiments, thereby revealing a new mechanism of QCS in UC treatment. ### Background and Objectives - **Background**: Qing Chang Suppository is a traditional Chinese medicine preparation that has been used in Longhua Hospital for more than 30 years and has satisfactory clinical efficacy for UC, but its treatment mechanism has not been fully elucidated. - **Objectives**: To study the role of QCS and its components in the treatment of UC by regulating the IL - 17A signaling pathway. ### Methods - **Chemical analysis**: High - performance liquid chromatography (HPLC) was used to analyze the main components of QCS (gallic acid, indigo, indirubin). - **In vitro experiments**: HT - 29 cells were induced with recombinant human IL - 17A and TNF - α, and the expression of IL - 17A - related proteins was detected by Western Blot. - **In vivo experiments**: A BALB/C mouse model was induced with 4% dextran sodium sulfate (DSS). The effects of QCS and its components were evaluated by measuring body weight loss, disease activity index (DAI), colon length, histological analysis, etc. Meanwhile, the expression of IL - 17A and MAPK - related proteins (p - ERK, p - JNK, p - P38) was analyzed by Western Blot, the gene expression of IL - 17A, HSP90 and ACT1 in colon tissues was detected by q - PCR, and the content of cytokines (such as IL - 17A, IL - 1β, IFN - γ and TNF - α) was detected by ELISA. ### Results - **In vitro experiment results**: QCS significantly inhibited the expression of IL - 17A, TRAF3 and the phosphorylation of ERK and P38. - **In vivo experiment results**: QCS significantly alleviated DSS - induced colitis in mice, reduced body weight loss, restored colon length, repaired colon lesions, decreased histological scores and DAI, reduced the content of TNF - α, IL - 1β, IL - 17 and IFN - γ, significantly inhibited the gene expression of IL - 17A, ACT1 and HSP90, and up - regulated the expression of tight junction proteins (such as ZO - 1 and Occludin). ### Conclusion This study shows that QCS plays a role in the treatment of UC in HT - 29 cells and DSS - induced mice by inhibiting the IL - 17A signaling pathway, revealing a new mechanism of QCS in UC treatment.

Effects of Qing Chang Suppository Powder and its Ingredients on IL-17 Signal Pathway in HT-29 Cells and DSS-induced Mice

Anti-inflammation effect of Qingchang suppository in ulcerative colitis through JAK2/STAT3 signaling pathway in vitro and in vivo

Qingchang suppository ameliorates mucosal inflammation in ulcerative colitis by inhibiting the differentiation and effector functions of Th1 and Th17 cells

Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways

Qingchang Wenzhong Decoction reduce ulcerative colitis in mice by inhibiting Th17 lymphocyte differentiation

Qingchang Suppository Ameliorates Colonic Vascular Permeability in Dextran-Sulfate-Sodium-Induced Colitis

Clinical, pharmacology and in vivo studies of QingDai (indigo naturalis) promotes mucosal healing and symptom improvement in ulcerative colitis by regulating the AHR-Th17/Treg pathway

Gegen Qinlian Decoction Relieved DSS-induced Ulcerative Colitis in Mice by Modulating Th17/Treg Cell Homeostasis Via Suppressing IL-6/JAK2/STAT3 Signaling

Qing-Chang-Hua-Shi granule ameliorates DSS-induced colitis by activating NLRP6 signaling and regulating Th17/Treg balance

Qingchi San treats ulcerative colitis in mice by inhibiting the nuclear factor-kappa B signaling pathway and Nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing 3 inflammasome formation

Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function

QingChang-XiaoPi Decoction Ameliorates Intestinal Inflammation of Ulcerative Colitis by Regulating the Pathogenicity of Th17 Cells

Experimental Study of Changyanqing for Colitis Induced by Dextran Sulfate Sodium

An investigation into the HIF-dependent intestinal barrier protective mechanism of Qingchang Wenzhong decoction in ulcerative colitis management

Therapeutic mechanism of Changyanqing in treatment of colitis induced by dextran sulfate sodium

Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway

Qingchang Wenzhong Decoction ameliorates intestinal inflammation and intestinal barrier dysfunction in ulcerative colitis via the GC-C signaling pathway

Mechanism of Qingchang Suppository on repairing the intestinal mucosal barrier in ulcerative colitis

The effect and mechanism of Huangqin-Baishao herb pair in the treatment of dextran sulfate sodium-induced ulcerative colitis

Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice

Protective effects and mechanisms of HuDiChangRong capsule on TNBS-induced ulcerative colitis in mice